Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY43.22 CNY
Change Today 0.00 / 0.00%
Volume 0.0
002644 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

lanzhou foci pharmaceutica-a (002644) Snapshot

Open
CNY47.00
Previous Close
CNY43.22
Day High
CNY47.25
Day Low
CNY43.22
52 Week High
06/11/15 - CNY65.50
52 Week Low
08/6/14 - CNY17.91
Market Cap
8.8B
Average Volume 10 Days
6.6M
EPS TTM
CNY0.20
Shares Outstanding
204.3M
EX-Date
06/24/15
P/E TM
221.6x
Dividend
CNY0.02
Dividend Yield
0.04%
Current Stock Chart for LANZHOU FOCI PHARMACEUTICA-A (002644)

Related News

No related news articles were found.

lanzhou foci pharmaceutica-a (002644) Related Businessweek News

No Related Businessweek News Found

lanzhou foci pharmaceutica-a (002644) Details

Lanzhou Foci Pharmaceutical Co., Ltd. manufacturers and distributes traditional Chinese medicines, western drugs, and raw herbs in China. It offers antibiotics; and products for gastrointestinal disorders and gynecological problems, as well as pediatric products. The company provides its products in various dosage forms, including pills, tablets, granules, capsules, concentrated decoctions, mixtures, oral liquids, syrups, and medicinal wines under the Min Shan and Foci brand names. It exports its products to approximately 27 countries and areas, which include the United States, the United Kingdom, Canada, Japan, Singapore, Indonesia, Thailand, Malaysia, Germany, the Netherlands, New Zealand, Australia, Russia, Ukraine, and Hong Kong. The company was founded in 1929 and is based in Lanzhou, China.

Founded in 1929

lanzhou foci pharmaceutica-a (002644) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lanzhou foci pharmaceutica-a (002644) Key Developments

Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Amendments to Articles of Association

Lanzhou Foci Pharmaceutical Co.,Ltd. proposed amendments to the company's articles of association, to its extraordinary general meeting of 2015 to be held on August 5, 2015.

Lanzhou Foci Pharmaceutical Co.,Ltd. to Report First Half, 2015 Results on Jul 17, 2015

Lanzhou Foci Pharmaceutical Co.,Ltd. announced that they will report first half, 2015 results on Jul 17, 2015

Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Cash Dividend for the Year 2014, Payable on June 24, 2015

Lanzhou Foci Pharmaceutical Co.,Ltd. announced cash dividend (tax included) of CNY 0.16000000 per 10 shares for the year 2014, payable on June 24, 2015. Record date is June 23, 2015 and ex-date is June 24, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002644:CH CNY43.22 CNY 0.00

002644 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002644.
View Industry Companies
 

Industry Analysis

002644

Industry Average

Valuation 002644 Industry Range
Price/Earnings 100.0x
Price/Sales 25.6x
Price/Book 7.3x
Price/Cash Flow 233.4x
TEV/Sales 23.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANZHOU FOCI PHARMACEUTICA-A, please visit www.fczy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.